Microalbuminuria as an early indicator of osteopenia in male insulin-dependent diabetic patients
✍ Scribed by Clausen, P.; Feldt-Rasmussen, B.; Jacobsen, P.; Rossing, K.; Parving, H-H.; Nielsen, P.K.; Feldt-Rasmussen, U.; Olgaard, K.
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 81 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0742-3071
No coin nor oath required. For personal study only.
✦ Synopsis
Reduced bone mineral density (BMD), termed diabetic osteopenia, has been reported in patients with insulin-dependent (Type 1) diabetes mellitus (IDDM). To examine BMD in long-term IDDM patients with normal kidney function, but with different degrees of urinary albumin excretion rate (UAER), compared to that of patients with elevated plasma creatinine, 36 IDDM male patients (mean duration 27 years) were subdivided according to UAER (Ͻ30, 30-300, Ͼ300, Ͼ300 mg 24 h -1 and plasma creatinine 0.120-0.350 mmol l -1 ) and 15 controls were recruited. BMD was measured by dual energy X-ray absorptiometry and UAER by enzyme linked immunosorbent assay. BMD was normal in IDDM patients with normal UAER and reduced in the femoral neck, the trochanter major, and the Wards triangle in patients with increased UAER (p Ͻ 0.01, p Ͻ 0.05, p Ͻ 0.02). BMD correlated to creatinine clearance in both cortical and cancellous bone sites (p Ͻ 0.001, p Ͻ 0.0001), and inversely to the levels of plasma PTH (p Ͻ 0.0005). We conclude that BMD is normal in long-term IDDM male patients with normal kidney function and normal UAER and reduced in patients with increased UAER. Diabetic osteopenia seems to be a progressive phenomenon related to diabetic nephropathy and associated with the decrease in creatinine clearance and with the resulting rise in plasma PTH.